EUVIMEDEUVIMED entdecken
BeobachtungsstudieVergleichsstudie

The impact of concurrent HIV-infection on women with vulvar cancer: Comparison of clinical characteristics and outcome

Jennifer L Butt iD, Judith S Jacobsen, Hannah M Simonds, Matthys H Botha

International Journal of STD & AIDS · 2025

DOI: 10.1177/09564624241287260 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift International Journal of STD & AIDS, 2025. Verfasst von Jennifer L Butt und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynaecology, Tygerberg Hospital, Stellenbosch University, South Africa. Hauptthemen laut MEDLINE: Vulvar Neoplasms, HIV Infections, Papillomavirus Infections. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: Center for Cancer Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

HPV-related vulvar cancer is increasing in prevalence, especially in women living with HIV. Treatment of vulva cancer is based on evidence from HPV-independent cancers, which affect older women. The impact of HIV on vulvar cancer characteristics and treatment outcomes needs to be elucidated. Patients and Methods A retrospective observational study compared the clinical characteristics, treatment, and outcomes of 92 HIV-positive and 131 HIV-negative women with vulvar cancer at our institution. Using descriptive statistics, HIV-positive and negative patients were compared and Cox regression models were tested for differences in mortality and recurrence.

Results

HIV-positive patients were 20 years younger than HIV-negative patients ( p < 0.001). More than 50% of patients presented with advanced stage cancer, however this was independent of HIV-status. Although HIV infection was associated with poorer survival ( p = 0.022); rates of cure ( p = 0.933) and recurrence rates ( p = 0.8) were similar in HIV-positive and negative women.

Conclusions

Vulvar cancer occurs at a much younger age in women living with HIV. Awareness among HIV-positive women and health care providers would lead to diagnosis of vulvar cancer at an earlier stage. Treatment protocols for HPV-related vulvar cancer should not be altered due to HIV status and should take into consideration the young age of the patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vulvar NeoplasmsHIV InfectionsPapillomavirus InfectionsHumansFemaleRetrospective StudiesAdultMiddle AgedTreatment OutcomeAgedNeoplasm Recurrence, LocalYoung Adult

Stichwörter der Autor:innen

Vulvar neoplasmsepidemiologyhuman immunodeficiency virus infectionpapillomavirus infectiontreatment outcomewomen

Autor:innen und Institutionen

  • Department of Obstetrics and Gynaecology, Tygerberg Hospital, Stellenbosch University, South Africa.
  • Department of Epidemiology, Mailman School of Public Health Columbia University, USA.
  • Department of Oncology, Tygerberg Hospital, Stellenbosch University.

ORCID-Profile: Jennifer L Butt

Förderung

  • Center for Cancer Research

Zitieren

APA

Butt, J. L., Jacobsen, J. S., Simonds, H. M., & Botha, M. H. (2025). The impact of concurrent HIV-infection on women with vulvar cancer: Comparison of clinical characteristics and outcome. International Journal of STD & AIDS. https://doi.org/10.1177/09564624241287260

Vancouver

Butt JL, Jacobsen JS, Simonds HM, Botha MH. The impact of concurrent HIV-infection on women with vulvar cancer: Comparison of clinical characteristics and outcome. International Journal of STD & AIDS. 2025. doi:10.1177/09564624241287260

BibTeX
@article{Butt2025,
  author = {Butt, Jennifer L and Jacobsen, Judith S and Simonds, Hannah M and Botha, Matthys H},
  title = {The impact of concurrent HIV-infection on women with vulvar cancer: Comparison of clinical characteristics and outcome},
  journal = {International Journal of STD & AIDS},
  year = {2025},
  doi = {10.1177/09564624241287260}
}
Kostenlos starten →